79 related articles for article (PubMed ID: 10346877)
1. Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTc.
Kim IS; Yoo TM; Kobayashi H; Kim MK; Le N; Wang QC; Pastan I; Carrasquillo JA; Paik CH
Bioconjug Chem; 1999; 10(3):447-53. PubMed ID: 10346877
[TBL] [Abstract][Full Text] [Related]
2. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
Kobayashi H; Yoo TM; Kim IS; Kim MK; Le N; Webber KO; Pastan I; Paik CH; Eckelman WC; Carrasquillo JA
Cancer Res; 1996 Aug; 56(16):3788-95. PubMed ID: 8706025
[TBL] [Abstract][Full Text] [Related]
3. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
[TBL] [Abstract][Full Text] [Related]
5. Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.
Webber KO; Kreitman RJ; Pastan I
Cancer Res; 1995 Jan; 55(2):318-23. PubMed ID: 7812965
[TBL] [Abstract][Full Text] [Related]
6. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
Yoo TM; Chang HK; Choi CW; Webber KO; Le N; Kim IS; Eckelman WC; Pastan I; Carrasquillo JA; Paik CH
J Nucl Med; 1997 Feb; 38(2):294-300. PubMed ID: 9025758
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
[TBL] [Abstract][Full Text] [Related]
9. Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.
Kobayashi H; Sun BF; Han ES; Kim MK; Le N; Wang QC; Nelson DL; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Jpn J Cancer Res; 1998 Apr; 89(4):436-44. PubMed ID: 9617350
[TBL] [Abstract][Full Text] [Related]
10. Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment.
Kobayashi H; Han ES; Kim IS; Le N; Rajagopal V; Kreitman RJ; Pastan I; Paik CH; Carrasquillo JA
Nucl Med Biol; 1998 May; 25(4):387-93. PubMed ID: 9639301
[TBL] [Abstract][Full Text] [Related]
11. Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagents.
Kim I; Kobayashi H; Yoo TM; Kim MK; Le N; Han ES; Wang QC; Pastan I; Carrasquillo JA; Paik CH
Nucl Med Biol; 2002 Nov; 29(8):795-801. PubMed ID: 12453588
[TBL] [Abstract][Full Text] [Related]
12. Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv.
Carrasquillo JA; Lang L; Whatley M; Herscovitch P; Wang QC; Pastan I; Eckelman WC
Cancer Res; 1998 Jun; 58(12):2612-7. PubMed ID: 9635587
[TBL] [Abstract][Full Text] [Related]
13. Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
Kim MK; Jeong HJ; Kao CH; Yao Z; Paik DS; Pie JE; Kobayashi H; Waldmann TA; Carrasquillo JA; Paik CH
Nucl Med Biol; 2002 Feb; 29(2):139-46. PubMed ID: 11823118
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.
Wu C; Jagoda E; Brechbiel M; Webber KO; Pastan I; Gansow O; Eckelman WC
Bioconjug Chem; 1997; 8(3):365-9. PubMed ID: 9177842
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
[TBL] [Abstract][Full Text] [Related]
16. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
17. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
[TBL] [Abstract][Full Text] [Related]
18. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
20. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]